Cabaletta Bio, Inc.
CABA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001759138
No open-market purchases or sales by Cabaletta Bio, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $490.4M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Cabaletta Bio, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 128 | 159 | +31 |
| Shares | 48.5M | 51.1M | +2.51M (+5.2%) |
| Value | $1.10B | $870.9M | −$230.9M (−21.0%) |
New holders (46)
Institutions that held Cabaletta Bio, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (15)
Institutions that held Cabaletta Bio, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Holocene Advisors, LP | 1,920,323 | $43.6M |
| Ikarian Capital, LLC | 216,620 | $4.92M |
| First Turn Management, LLC | 175,359 | $3.98M |
| Rokos Capital Management LLP | 80,335 | $1.82M |
| Nicholas Investment Partners, LP | 54,586 | $1.24M |
| Exome Asset Management LLC | 46,700 | $1.06M |
| Bridgeway Capital Management, LLC | 46,021 | $1.04M |
| Advisory Research Inc | 17,660 | $400.9K |
| HRT Financial LP | 13,958 | $316.0K |
| Prelude Capital Management, LLC | 11,100 | $252.0K |
| State Board of Administration of Florida Retirement System | 9,830 | $223.1K |
| SG Americas Securities, LLC | 9,740 | $221.0K |
| Group One Trading, L.P. | 3,397 | $77.1K |
| Allspring Global Investments Holdings, LLC | 1,164 | $26.4K |
| Federated Hermes, Inc. | 132 | $3.00K |